Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-122,800
Closed -$13.9M 3013
2024
Q3
$13.9M Buy
122,800
+25,800
+27% +$3.07M 0.03% 377
2024
Q2
$12M Sell
97,000
-195,400
-67% -$25.2M 0.03% 427
2024
Q1
$38.6M Buy
292,400
+143,300
+96% +$17.7M 0.07% 138
2023
Q4
$16.3M Sell
149,100
-85,100
-36% -$8.83M 0.03% 407
2023
Q3
$24.1M Buy
+234,200
New +$25.2M 0.04% 278

Other funds holding MRK

GTS Securities's MRK Position: Q1 2026 in Review

GTS Securities reduced its Merck (MRK) stake by 72% in Q1 2026, selling an estimated $2.75M and leaving 9,305 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #352.

GTS Securities first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.61M in Q4 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • GTS Securities held 9,305 shares of Merck worth $1.12M as of Q1 2026.
  • GTS Securities sold 23,789 Merck shares in Q1 2026, an estimated $2.75M.
  • Merck made up 0.04% of GTS Securities's portfolio in Q1 2026, its #352 holding.
  • GTS Securities first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Merck position peaked at $4.61M in Q4 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.